Bingham Osborn & Scarborough LLC Reduces Stock Holdings in UnitedHealth Group Inc (NYSE:UNH)

Bingham Osborn & Scarborough LLC lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 4.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,224 shares of the healthcare conglomerate’s stock after selling 62 shares during the quarter. Bingham Osborn & Scarborough LLC’s holdings in UnitedHealth Group were worth $266,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Eagle Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 0.9% in the third quarter. Eagle Asset Management Inc. now owns 45,321 shares of the healthcare conglomerate’s stock valued at $9,849,000 after purchasing an additional 399 shares during the period. CNB Bank boosted its stake in UnitedHealth Group by 77.6% during the third quarter. CNB Bank now owns 1,767 shares of the healthcare conglomerate’s stock worth $384,000 after buying an additional 772 shares during the period. Essex Financial Services Inc. boosted its stake in UnitedHealth Group by 5.5% during the third quarter. Essex Financial Services Inc. now owns 10,349 shares of the healthcare conglomerate’s stock worth $2,249,000 after buying an additional 544 shares during the period. First Trust Advisors LP boosted its stake in UnitedHealth Group by 48.6% during the third quarter. First Trust Advisors LP now owns 484,288 shares of the healthcare conglomerate’s stock worth $105,245,000 after buying an additional 158,341 shares during the period. Finally, Haverford Trust Co. boosted its stake in UnitedHealth Group by 4.7% during the third quarter. Haverford Trust Co. now owns 492,240 shares of the healthcare conglomerate’s stock worth $106,974,000 after buying an additional 22,155 shares during the period. 85.66% of the stock is owned by hedge funds and other institutional investors.

UNH has been the subject of several research analyst reports. Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Credit Suisse Group set a $293.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Thursday, August 29th. Citigroup lowered their target price on shares of UnitedHealth Group from $299.00 to $286.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Raymond James increased their target price on shares of UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Jefferies Financial Group lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $300.00 to $235.00 in a research note on Thursday, October 10th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $283.84.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

In related news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the sale, the director now owns 187,979 shares of the company’s stock, valued at $43,874,298.60. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the sale, the director now directly owns 187,979 shares in the company, valued at approximately $43,517,138.50. The disclosure for this sale can be found here. Insiders have sold 33,177 shares of company stock worth $7,842,582 in the last three months. Corporate insiders own 0.87% of the company’s stock.

Shares of UNH opened at $256.97 on Friday. The stock has a market capitalization of $237.20 billion, a PE ratio of 19.95, a P/E/G ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.67 and a current ratio of 0.70. The company’s 50-day simple moving average is $234.76 and its 200-day simple moving average is $241.05.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.75 by $0.13. The business had revenue of $60.35 billion for the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.41 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Inc will post 14.96 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio is presently 33.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What are the Benefits of Index Funds?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Leave a Reply

Your email address will not be published. Required fields are marked *

*